Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palmitoylcarnitine, a surface-active metabolite

F M Goñi1, M A Requero, A Alonso

  • 1Grupo Biomembranas, Unidad Asociada al CSIC, Departamento de Bioquímica, Universidad del País Vasco, Aptdo, Bilbao, Spain.

FEBS Letters
|July 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compartmentalization of ceramide signaling: physical foundations and biological effects.

Journal of cellular physiology·2000
Same author

Oscillatory activity in entorhinal neurons and circuits. Mechanisms and function.

Annals of the New York Academy of Sciences·2000
Same author

[VIGILA: a tool for the epidemiologic surveillance of transmissible diseases].

Revista cubana de medicina tropical·2000
Same author

HLA-DR51 expression failure caused by a two-base deletion at exon 2 of a DRB5 null allele (DRB5*0110N) in a Spanish gypsy family.

Tissue antigens·2000
Same author

Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance.

Antimicrobial agents and chemotherapy·2000
Same author

A randomized field trial of ACINDES: a child-centered training model for children with chronic illnesses (asthma and epilepsy).

Journal of urban health : bulletin of the New York Academy of Medicine·2000

Palmitoylcarnitine, an intermediate in fatty acid oxidation, acts as a surfactant capable of solubilizing membranes. Its properties may explain mitochondrial fatty acid import mechanisms and its role in myocardial ischemia.

Area of Science:

  • Biochemistry
  • Mitochondrial Biology
  • Cardiovascular Pathophysiology

Background:

  • Palmitoylcarnitine is recognized for its role in mitochondrial fatty acid oxidation.
  • Its function as a surfactant, similar to laboratory detergents, is less understood.
  • This amphiphilic nature is key to its biological interactions.

Purpose of the Study:

  • To explore the surfactant properties of palmitoylcarnitine.
  • To elucidate the role of palmitoylcarnitine's physico-chemical characteristics in mitochondrial fatty acid import.
  • To investigate the connection between palmitoylcarnitine and the pathogenesis of myocardial ischemia.

Main Methods:

  • Physico-chemical characterization of palmitoylcarnitine.
  • Analysis of its membrane-solubilizing capacity.

Related Experiment Videos

  • Correlation of properties with known biochemical pathways.

    • Main Results:

    • Palmitoylcarnitine exhibits significant surfactant properties, capable of solubilizing biological membranes.
    • Its amphiphilic nature provides insights into the coenzyme A-carnitine-coenzyme A acyl exchange mechanism.
    • The surfactant activity is linked to its proposed involvement in myocardial ischemia.

    Conclusions:

    • Palmitoylcarnitine's surfactant activity is a critical, yet underappreciated, characteristic.
    • Understanding these properties enhances knowledge of mitochondrial fatty acid import.
    • Palmitoylcarnitine's amphiphilic nature is relevant to its role in heart disease pathogenesis.